MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, a novel, dual ...
3dOpinion
The Same But Different: As Turbulence Continues, Manufacturers Must Dare To Re-Write The Rules
Having become accustomed to dealing with isolated, manageable threats, the industry now faces risks that are interconnected ...
Agentic AI is redefining decision-making with autonomous systems that act, adapt, and execute. Reshape the future of business ...
Holiday lights, a Christmas tree and hot chocolate marked the opening of a multi-use path at the new QTS Data Center on ...
As multinationals embed tax technology into their TP functions, a new breed of systems – built on multi model databases – is ...
Sir Isaac Julien unveils a breathtaking new film installation at Palazzo Te in Mantua that bridges Renaissance myth with ...
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, and CT imaging plays a crucial ...
Innovid, the independent software platform for the creation, delivery, measurement, and optimization of advertising, today unveiled new AI agents alongside Innovid Orchestrator (TM)--the industry's ...
In the traditional view, affordances exist as options users perceive and act upon within their environment. However, in the age of genAI, affordances have become relational folds, dynamic exchanges in ...
To develop a mindset is not an easy task especially when it comes to embarking on entrepreneurial activities but the mindset ...
MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback